Home
Live Updates
Theravance Biopharma, Inc. (NASDAQ:TBPH) Q4 2023 Earnings Call Transcript : comparemela.com
Theravance Biopharma, Inc. (NASDAQ:TBPH) Q4 2023 Earnings Call Transcript
Theravance Biopharma, Inc. beats earnings expectations. Reported EPS is $0.03, expectations were $-0.04.
Related Keywords
China ,
London ,
City Of ,
United Kingdom ,
United States ,
Japan ,
Rick Winningham ,
Douglas Tsao ,
Theravance Biopharma ,
David Risinger ,
Rhonda Farnum ,
Aziz Sawaf ,
Head Of Development ,
Nasdaq ,
Theravance Biopharma Inc ,
National Institutes Of Health ,
Department Of Neurosciences ,
Call Transcript February ,
Theravance Biopharma Fourth Quarter ,
Chief Executive ,
Raine Miller ,
Chief Business Officer ,
Chief Financial ,
Inflation Reduction ,
National Institutes ,
Gold Report ,
Best Paying Jobs ,
Best Job ,
comparemela.com © 2020. All Rights Reserved.